Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aileron Therapeutics Inc (ALRN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011802
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aileron Therapeutics Inc (Aileron) is a biopharmaceutical company that develops and commercializes novel class of therapeutics. The company provides products such as stapled peptide drugs. Its stapled peptides penetrate cells throughout the body and modulate intracellular protein-protein interactions. Aileron’s product candidate ALRN-6924, targets the tumor suppressor protein p53 for the treatment of cancers. The company’s products are used for therapeutic areas of cancer, inflammation, and endocrine and metabolic diseases. It uses peptide stabilization technology. The company partners with research organizations. Aileron is headquartered in Cambridge, Massachusetts, the US.

Aileron Therapeutics Inc (ALRN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aileron Therapeutics Raises USD33 Million in Extended Series E Venture Financing 10
Aileron Therapeutics Raises US$30 Million In Series E Financing 12
Aileron Raises US$12 Million In Extended Series D Financing 14
Partnerships 16
Roche Expands Co-Development Agreement With Aileron Therapeutics 16
Equity Offering 17
Aileron Therapeutics Raises USD56.3 Million in IPO 17
Aileron Therapeutics Raises USD19 Million in Private Placement of Shares 19
Aileron Therapeutics Inc – Key Competitors 20
Aileron Therapeutics Inc – Key Employees 21
Aileron Therapeutics Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Financial Announcements 23
Nov 09, 2017: Aileron Therapeutics Reports Third Quarter 2017 Financial Results 23
Aug 10, 2017: Aileron Therapeutics Reports Second Quarter 2017 Financial Results 25
Corporate Communications 27
Jun 15, 2017: Aileron Therapeutics Appoints Donald Dougherty as Senior Vice President and Chief Financial Officer 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aileron Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Aileron Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aileron Therapeutics Raises USD33 Million in Extended Series E Venture Financing 10
Aileron Therapeutics Raises US$30 Million In Series E Financing 12
Aileron Raises US$12 Million In Extended Series D Financing 14
Roche Expands Co-Development Agreement With Aileron Therapeutics 16
Aileron Therapeutics Raises USD56.3 Million in IPO 17
Aileron Therapeutics Raises USD19 Million in Private Placement of Shares 19
Aileron Therapeutics Inc, Key Competitors 20
Aileron Therapeutics Inc, Key Employees 21

★海外企業調査レポート[Aileron Therapeutics Inc (ALRN)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mahindra & Mahindra Limited:企業のM&A・提携・投資分析
    Mahindra & Mahindra Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mahindra & Mahindra Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Bio-Reference Laboratories, Inc. (BRLI):企業の財務及び戦略的SWOT分析
    Bio-Reference Laboratories, Inc. (BRLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Air Canadaの企業概要及び財務/SWOT分析
    Air Canada Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Air Canada annual and quarterly forecasts made by stock market experts. The report also enables direct comparison t …
  • Conergy AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Conergy AG Mergers and Acquisit …
  • TGC Industries, Inc. (TGE):企業概要、財務及び戦略的SWOT分析
    Summary TGC Industries, Inc. (TGC Industries) is a geophysical service provider. The company provides geophysical services to oil and gas companies. Its services include acquisition, vibroseis, drilling services, surveying services, and others. TGC Industries' drilling service provides flexibility o …
  • Cadila Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Cadila Pharmaceuticals Ltd (Cadila Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes pharmaceutical products. The company's products include active pharmaceutical ingredients (API) and pharmaceutical formulations. Its business includes contract research …
  • Great Eastern Holdings Ltd.の企業概要及び財務/SWOT分析
    Great Eastern Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and qua …
  • CMG Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CMG Holdings, Inc. Mergers and …
  • Great Eastern Holdings Limited (G07):企業の財務及び戦略的SWOT分析
    Great Eastern Holdings Limited (G07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Echo Therapeutics Inc (ECTE):企業のM&A・提携動向(医療機器分野)
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • Astino Bhdの企業概要及び財務/SWOT分析
    Astino Bhd Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts …
  • IFFCO-Tokio General Insurance Co. Ltd.:企業の戦略・SWOT・財務分析
    SummaryIFFCO-Tokio General Insurance Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of t …
  • Oncobiologics Inc (ONSIU):企業のM&A・提携動向(医療分野)
    Summary Oncobiologics Inc (Oncobiologics) is a biopharmaceutical company that develops, manufactures and commercializes monoclonal antibodies biosimilars in the therapeutic areas of oncology and immunology. The company's ONS-3010 is a biosimilar of Humira; and ONS-1045 is a biosimilar of Avastin, wh …
  • Auto Escape SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Auto Escape SA Mergers and Acqu …
  • HUGO BOSS AG:企業の戦略・SWOT・財務分析
    HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report Summary HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Parkson Retail Group Limited:戦略・SWOT・企業財務分析
    Parkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report Summary Parkson Retail Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Siva Group (formerly Sterling Infotech Group):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Siva Group (formerly Sterling I …
  • Persistent Systems Limited (PERSISTENT):企業財務及び戦略的SWOT分析
    Summary Persistent Systems Limited (Persistent) is a software development company that develops and maintains software systems and solutions. The company's software product DNA comprise product concept and design, agile product engineering, performance engineering, professional services, and others. …
  • Oldfields Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Oldfields Holdings Limited Merg …
  • Perspective Financial Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Perspective Financial Group Lim …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆